Drug Shortage Report for FASTURTEC

Last updated on 2023-10-04 History
Report ID 193234
Drug Identification Number 02248416
Brand name FASTURTEC
Common or Proper name FASTURTEC
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) RASBURICASE
Strength(s) 1.5MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3 vials
ATC code V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-05-26
Actual start date 2023-05-25
Estimated end date 2023-09-29
Actual end date 2023-10-03
Shortage status Resolved
Updated date 2023-10-04
Company comments Health Canada has allowed the temporary importation and distribution of Great Britain –labelled product. Lot No. 3J1011, Expiry Date:28.02.2026, PLGB 04425/0821 Please contact LAVALCS@sanofi.com in case of questions.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-05-26 English Compare
v2 2023-05-26 French Compare
v3 2023-06-09 English Compare
v4 2023-06-09 French Compare
v5 2023-06-09 English Compare
v6 2023-06-09 French Compare
v7 2023-07-21 English Compare
v8 2023-07-21 French Compare
v9 2023-09-19 English Compare
v10 2023-09-19 French Compare
v11 2023-10-03 English Compare
v12 2023-10-03 French Compare
v13 2023-10-03 English Compare
v14 2023-10-03 French Compare
v15 2023-10-04 English Compare

Showing 1 to 15 of 15